redbiotec provides a disruptive, patented technology platform to develop and produce innovative therapies and biomanufacturing solutions based on protein complexes and engineered microorganisms. founded in 2006 as a spin-off of eth zürich, the company has since won several awards, including the renowned w.a. de vigier award.